1. Home
  2. BCYC vs AMBC Comparison

BCYC vs AMBC Comparison

Compare BCYC & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • AMBC
  • Stock Information
  • Founded
  • BCYC 2009
  • AMBC 1971
  • Country
  • BCYC United Kingdom
  • AMBC United States
  • Employees
  • BCYC N/A
  • AMBC N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • AMBC Property-Casualty Insurers
  • Sector
  • BCYC Health Care
  • AMBC Finance
  • Exchange
  • BCYC Nasdaq
  • AMBC Nasdaq
  • Market Cap
  • BCYC 449.5M
  • AMBC 392.1M
  • IPO Year
  • BCYC 2019
  • AMBC 1991
  • Fundamental
  • Price
  • BCYC $6.30
  • AMBC $9.08
  • Analyst Decision
  • BCYC Buy
  • AMBC Strong Buy
  • Analyst Count
  • BCYC 11
  • AMBC 1
  • Target Price
  • BCYC $20.73
  • AMBC $15.00
  • AVG Volume (30 Days)
  • BCYC 345.2K
  • AMBC 788.1K
  • Earning Date
  • BCYC 10-30-2025
  • AMBC 11-10-2025
  • Dividend Yield
  • BCYC N/A
  • AMBC N/A
  • EPS Growth
  • BCYC N/A
  • AMBC N/A
  • EPS
  • BCYC N/A
  • AMBC N/A
  • Revenue
  • BCYC $28,339,000.00
  • AMBC $254,480,000.00
  • Revenue This Year
  • BCYC N/A
  • AMBC $3.54
  • Revenue Next Year
  • BCYC N/A
  • AMBC N/A
  • P/E Ratio
  • BCYC N/A
  • AMBC N/A
  • Revenue Growth
  • BCYC N/A
  • AMBC 142.82
  • 52 Week Low
  • BCYC $6.10
  • AMBC $5.99
  • 52 Week High
  • BCYC $21.60
  • AMBC $13.64
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 36.23
  • AMBC 54.19
  • Support Level
  • BCYC $6.17
  • AMBC $8.13
  • Resistance Level
  • BCYC $6.89
  • AMBC $9.69
  • Average True Range (ATR)
  • BCYC 0.46
  • AMBC 0.49
  • MACD
  • BCYC -0.07
  • AMBC 0.05
  • Stochastic Oscillator
  • BCYC 7.91
  • AMBC 45.67

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About AMBC Ambac Financial Group Inc.

Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.

Share on Social Networks: